Icosavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Icosavax and buy or sell other stocks, ETFs, and their options commission-free!

About ICVX

Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. 

CEO
Adam K. Simpson
CEOAdam K. Simpson
Employees
Employees
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2017
Founded2017
Employees
Employees

ICVX Key Statistics

Market cap
766.86M
Market cap766.86M
Price-Earnings ratio
-6.89
Price-Earnings ratio-6.89
Dividend yield
Dividend yield
Average volume
1.04M
Average volume1.04M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$16.11
52 Week high$16.11
52 Week low
$4.75
52 Week low$4.75

People also own

Based on the portfolios of people who own ICVX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.